Accelarated cross-linking | 131 | Juxtaglomerular cell tumor | 287 | |
Acetyl salicylic acid | 269 | Kawasaki disease | 324 | |
Acute lymphoblastic leukemia | 138 | Keratoconus | 131 | |
Acute myeloid leukemia | 138 | Kidney neoplasm | 287 | |
Acute myocardial infarction | 276 | Large vessel occlusion | 253 | |
Adenosine stress adequacy | 260 | Left distal artery | 276 | |
Adrenergic alpha-2 receptor antagonists | 189 | Liver transplantation | 196 | |
Adult | 121 | Lung cancer | 208 | |
Allogeneic hematopoietic stem cell transplantation | 138 | Lung cancer | 29 | |
Analgesics | 189 | Magnetic resonance imaging | 336 | |
Anterior cerebral circulation | 24 | MCF 7 | 98 | |
Antimicrobial resistance | 215 | Mechanical thrombectomy | 253 | |
Apoptosis | 29 | Melanoma | 15 | |
Autoinflammatory diseases | 236 | Metformin | 196 | |
Bleeding | 108 | Methadone | 247 | |
Blood pressure variability | 253 | MicroRNAs | 60 | |
Botulinum toxin-A | 84 | Middle cerebral artery infarction | 24 | |
Brain metastasis | 208 | Military medicine | 3 | |
Breast cancer | 104 | Molecular docking | 189 | |
Bulgaria | 330 | Molecular epidemiology | 125, 215 | |
Buprenorphine | 247 | MOLLI | 260 | |
Cancer | 330 | Morbidity | 157 | |
Carcinoid tumor | 281 | Moringa peregrina | 189 | |
Cardiac ganglia | 79 | N-myc downstream regulated gene-1 | 15 | |
Cardiac magnetic resonance | 260 | Neonatal intensive care unit | 150 | |
Cardiac troponin I | 72 | Neonatal mortality | 144 | |
Cardiotoxicity | 98 | Neuroendocrine tumor | 281 | |
Cardiovascular disease | 60 | Newborn | 150 | |
Caspases | 29 | Novel coronavirus pneumonia | 163 | |
Catalase | 98 | NSAIDs | 309 | |
Causes | 144 | Opioid use disorder | 247 | |
CDK4/6 inhibitors | 104 | Optical coherence tomography angiography | 9 | |
Cell study | 29 | Oral immunotherapy | 316 | |
Cell-free DNA | 138 | Osteoporosis | 348 | |
Cerebral autoregulation | 253 | Palbociclib | 104 | |
Childhood | 236 | Paracetamol | 309 | |
Children | 34, 47, 316, 341 | Pathological yawning | 24 | |
Choroid | 9 | PC-14/B cells | 208 | |
Chronic disease | 34 | Pediatrics | 184 | |
Chronic obstructive pulmonary disease | 157 | Perfusion | 253 | |
Chronic pain | 247 | Perioperative management | 247 | |
Classification | 236 | Phenotype | 43 | |
Co-infection | 125 | Platelet mass index | 150 | |
Coagulase-negative staphylococci | 215 | Platelet transfusion | 150 | |
Coccydynia | 348 | Power Doppler ultrasound | 203 | |
Coccygeoplasty | 348 | Prevalence | 157 | |
Coil/device/transcatheter | 108 | Primary percutaneous intervention | 276 | |
Coma | 131 | Primary Sjögren’s syndrome | 203 | |
Computed tomography | 163 | Prognosis | 24, 236 | |
Congenital anomaly | 47 | Prognosis study | 324 | |
Corneal cross-linkin | 131 | Prognostic factor | 91 | |
Coronary artery lesions | 324 | Propeller perforator pedicle flap | 84 | |
Coronary atherosclerosis | 79 | Pseudoexfoliation | 9 | |
Coronary heart disease | 260 | PTK-7 | 91 | |
COVID-19 | 184, 341 | Pulmonary complications | 163 | |
Cow’s milk allergy | 316 | Quality of life | 34 | |
Cxl | 131 | R-(-)-carvone | 98 | |
Cytotoxicity | 29 | Rabbits | 79 | |
Diagnosis | 47, 163 | Rats | 84 | |
Dipyrone | 309 | Recanalization | 253 | |
Disease | 108 | Refugees | 341 | |
Doxorubicin | 98 | Renal artery intervention | 108 | |
Dynamic enhanced computed tomography | 287 | Retina | 9 | |
Embolization | 108 | Rheumatology | 184 | |
Endocannabinoids | 309 | Risk factors | 72 | |
Endovascular thrombectomy | 253 | Salivary glands | 203 | |
ENG mutations | 43 | SARS virus | 184 | |
Epidemiology | 330 | SasX | 215 | |
Esophageal atresia | 47 | SCCmec | 215 | |
Fatty liver | 196 | Scintigraphy | 84 | |
Favipiravir | 341 | Secondary hypertension | 287 | |
Flap necrosis | 84 | Sepsis | 72 | |
Focused assessment | 3 | Septic cardiomyopathy | 72 | |
Fracture | 348 | Serbia | 144 | |
Gastric cancer | 91 | ShMOLLI | 260 | |
Gastroenteropancreatic neuroendocrine tumor | 281 | Sibling | 34 | |
Gene expression | 60 | Sirtuin 1 | 208 | |
Genotype | 43 | sTWEAK | 336 | |
H9C2 | 98 | Superb microvascular imaging | 203 | |
Heparin | 269 | Surgery | 47, 247 | |
Hepatitis B virus | 125 | Survival analysis | 324 | |
Hepatitis C virus | 125 | T1 mapping | 260 | |
Hereditary hemorrhagic telangiectasia | 43 | Testicular | 121 | |
HIV-1 | 125 | Testosterone | 121 | |
Higher-order aberations | 131 | Thrombocytopenia | 150 | |
Histones | 72 | Thrombosis | 269 | |
Hsa-miRNA-217 | 208 | Thyroid | 330 | |
Hydrogel | 269 | Ticagrelor | 269 | |
Hydroxychloroquine | 184 | Tocilizumab | 184 | |
Hypertension | 253 | Tracheoesophageal fistula | 47 | |
Hypoxia | 15 | Trauma | 3 | |
Hypoxia-inducible factor-1 beta | 15 | Treatment | 236 | |
Infarct location | 24 | Turkey | 157, 341 | |
Inflammation | 196 | Ultrasonography | 84, 203 | |
Influenza | 163 | Ultrasound | 3 | |
Intraventricular hemorrhage | 150 | Urinary tract | 121 | |
Ischemia-reperfusion injury | 196 | Vagal nerve | 79 | |
Ischemic area volüme | 336 | Varicocele | 121 | |
Ischemic stroke | 253, 336 | Vascular structure | 9 | |
İncidence | 330 | Vein bypass graft | 269 | |
İnjury | 3 | Wagonin | 29 |